Molecular Breast Imaging Market will worth USD 10.65 billion by 2030 : GreyViews

Molecular Breast Imaging Market Size By Application (Diagnosis, Detection and Others), By End -User (Research Centers, Hospitals & Clinics, Diagnostic Centers and Ambulatory Surgical Centers), Regions, Segmentation, and forecast till 2030.


Pune India, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the molecular breast imaging market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the molecular breast imaging market are present across various countries in the above-mentioned regions.

Get Sample Copy of This Report @ https://greyviews.com/reports/molecular-breast-imaging-market/289/request-sample

The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as the application, end-user, and regions. Apart from this, the key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the below paragraphs.
The significant players operating in the global molecular breast imaging market are ESAOTE SPA, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, ONEX Corporation,Sanrad Medical Systems Private Limited, Hologic, Inc., Koning Health, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., CANON MEDICAL SYSTEMS CORPORATION, Aurora Health Care, Imaging Diagnostic Systems, Inc., General Electric, Hitachi Ltd., Bruker, Aspect Imaging Ltd, Koninklijke Philips N.V., Neusoft Corporation, FONAR Corp., Agfa-Gevaert Group, TOSHIBA CORPORATION, among others. To achieve a substantial market share in the worldwide molecular breast imaging market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.
Molecular breast imaging involves taking pictures of tissues in the breast using a special camera and radioactive tracer to look for signs of breast cancer. Several technologies have been developed for detecting breast cancer since the number of women suffering from the disease has increased significantly. There are some factors which are hindering the growth of the market such as a lack of awareness about breast cancer, the high cost of technology etc. A major challenge preventing the growth of the market in developing regions is the high cost of technology. Furthermore, researchers and developers are continually improving the treatment options available, shaping the market and the technology is advancing, which results in a faster acquisition time, higher sensitivity, and greater specificity.
Enquiry Before Buying This Report @  https://greyviews.com/inquiry/289

Scope of Molecular Breast Imaging Market Report:

Report MetricInformation
Study Period2022-2030
Base Year           2022
Forecast Period2023-2030
Market Share UnitUSD Billion
Segments CoveredApplication, End-User, and Regions.
Regions CoveredNorth America, Europe, Asia-Pacific, South America, and Middle-East and Africa
Major PlayersESAOTE SPA, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, ONEX Corporation,Sanrad Medical Systems Private Limited, Hologic, Inc., Koning Health, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., CANON MEDICAL SYSTEMS CORPORATION, Aurora Health Care, Imaging Diagnostic Systems, Inc., General Electric, Hitachi Ltd., Bruker, Aspect Imaging Ltd, Koninklijke Philips N.V., Neusoft Corporation, FONAR Corp., Agfa-Gevaert Group, TOSHIBA CORPORATION, among others.

Segmentation Analysis

Diagnosis is expected to be the fastest-growing segment in 2022. 

The application segment includes diagnosis, detection and others. The diagnosis segment is expected to witness the highest growth rate during the forecast period. Breast imaging services available in developed and developing economies, such as the U.S., Germany, the U.K., Japan, China, and India, are expected to drive the segment's growth. Furthermore, in order to reduce hospital and payer expenditures, firms in the global breast cancer diagnostics market are using artificial intelligence to improve medical results. AI technology is rapidly being deployed in much more imaging modalities, propelling the growth of the market.

 Hospitals & clinics are expected to be the fastest-growing segment in 2022. 

The end-user segment includes research centres, hospitals & clinics, diagnostic centres and ambulatory surgical centres. The hospitals & clinics segment is expected to witness the highest growth rate during the forecast period. Despite the segment has dominated the market in the past with the highest revenue share, increasing investment in healthcare infrastructure around the globe will contribute to the market's growth in the future.

Regional Analysis

The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the molecular breast imaging market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia.

The North American region witnessed a major share. Due to the high prevalence of breast cancer among women and the increased awareness of breast cancer within the region, the molecular breast imaging (MBI) market is dominated by North America. Additionally, the presence of major manufacturers and technological advancements continue to expand the market.

Country Analysis

  • Germany

Germany's molecular breast imaging market size was valued at USD 0.37 billion in 2022 and is expected to reach USD 0.82 billion by 2030, at a CAGR of 10.4% from 2023 to 2030. Due to the public and private sectors' ongoing financial and investment support for cancer research rising the industry's expansion in Germany.

  • China

China’s molecular breast imaging market size was valued at USD 0.38 billion in 2022 and is expected to reach USD 0.85 billion by 2030, at a CAGR of 10.7% from 2023 to 2030. China's molecular breast imaging market is rising due to increase in mobile solutions and contract-based diagnostics.

  • India

India's molecular breast imaging market size was valued at USD 0.29 billion in 2022 and is expected to reach USD 0.64 billion by 2030, at a CAGR of 10.6% from 2023 to 2030. Because of rising government efforts to upgrade healthcare facilities in India and a rise in the target patient population.
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.

Furthermore, the growth of molecular breast imaging market is mainly driven owing to the rising cases of breast cancer.

Buy Now Full Report @ https://greyviews.com/checkout/289/single_user_license

Contact Us

Rocky Shah

GreyViews

Pune India

Phone: (+44) 162-237-1047

Email: sales@greyviews.com

Web: https://greyviews.com/

Follow Us: LinkedIn | Twitter

Browse Related Reports:

Hemodynamic Monitoring System Market Size By System (Invasive Monitoring Systems, Minimally Invasive Monitoring Systems, and Non-invasive Monitoring Systems), By End-User (Catheterization Laboratories, Hospitals, and Others), Regions, Segmentation, and Projection till 2030

https://greyviews.com/reports/hemodynamic-monitoring-system-market/372

Dermatology Lasers Market Size By Type (Gem Laser Machine, Gas Laser Machine, and Semiconductor Laser Machine), By Application (Beauty and Skin Diseases), Regions, Segmentation, and Projection till 2030

https://greyviews.com/reports/dermatology-lasers-market/370

Pharmaceutical Glass Packaging Market Size By Product (Bottles, Vials, Cartridges & Syringes, and Ampoules), By Drug Type (Branded, Biologic and Generic), Regions, Segmentation, and Projection till 2030

https://greyviews.com/reports/pharmaceutical-glass-packaging-market/367

Pharmaceuticals Preservative Market Size By Source (Natural Pharmaceuticals Preservative Agents and Synthetic Pharmaceuticals Preservative Agents), By Function (Antioxidants Pharmaceuticals Preservative Agents, Antimicrobial Pharmaceuticals Preservative Agents, and Chelating Pharmaceuticals Preservative Agents), Regions, Segmentation, and Projection till 2030  

https://greyviews.com/reports/pharmaceuticals-preservative-market/361

Ophthalmic Drugs Market Size By Drug Class (Anti-Inflammatory, Anti-Glaucoma, Anti-VEGF Agents, Antiallergy, and Others), By Disease (Glaucoma, Eye Allergy, Eye Infection, Uveitis, Dry Eye, Retinal Disorders, and Others), By Dosage Form (Eye Solutions & Suspensions, Eye Drops, Gels, Capsules and Tablets, and Ointments), Regions, Segmentation, and Projection till 2030        

https://greyviews.com/reports/ophthalmic-drugs-market/357

Neurosurgery Surgical Power Tools Market Size By Tools Type (Drill, Reamer, Saw, and Others), By Power Type (Pneumatic, Electric, and Battery Powered), Regions, Segmentation, and Projection till 2030          

https://greyviews.com/reports/neurosurgery-surgical-power-tools-market/356

Neonatal Phototherapy Devices Market Size By Light Source (Light-emitting diodes (LEDs), Quartz halogen lamps, Gas discharge tubes, and Fluorescent lamps (FL)), By Configuration (Mobile device and Fixed device), By End-User (Hospitals and Neonatal clinics), Regions, Segmentation, and Projection till 2030

https://greyviews.com/reports/neonatal-phototherapy-devices-market/355

Minimally Invasive Cataract Surgery Devices Market Size By Type (Stand-Alone Glaucoma, Phacoemulsification, Glaucoma in Conjunction with Cataract, Femtosecond Laser Surgery and Extracapsular Cataract Extraction Surgery), By End-User (Ophthalmology Clinic, Hospitals, Outpatient Surgery Centre and Others), Regions, Segmentation, and Projection till 2030       

https://greyviews.com/reports/minimally-invasive-cataract-surgery-devices-market/354

Healthcare Cold Chain Logistics Market Size By Type (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others), By Services (Transportation, Storage, and Others), Regions, Segmentation, and Projection till 2030        

https://greyviews.com/reports/healthcare-cold-chain-logistics-market/353

Disposable Syringes Market Size By Product (Conventional Syringes and Safety Syringes), By Application (Immunization Injections and Therapeutic Injections), Regions, Segmentation, and Projection till 2030         

https://greyviews.com/reports/disposable-syringes-market/351